The inherent differentiation program of short-term hematopoietic repopulating cells changes during human ontogeny.

Human umbilical cord blood (CB) could be an attractive source of hematopoietic repopulating cells for clinical stem cell therapy because of its accessibility and low propensity for unwanted immune reaction against the host. However, CB recipients suffer from severely delayed and often chronically deficient platelet recovery of unknown cause. Here we show that human short-term repopulating cells (STRCs), which predominantly carry early hematopoietic reconstitution after transplantation, display an intrinsically fixed differentiation program in vivo that changes during ontogeny. Compared to adult sources of hematopoietic cells, CB myeloidrestricted STRC-M showed a markedly reduced megakaryocytic and erythroid cell output in the quantitative xenotransplantation of human short-term hematopoiesis in NOD/SCID-beta2m(-/-) mice. This output in vivo was not altered by pre-treating CB cells before transplantation with growth factors that effectively stimulate megakaryocytopoiesis in vitro. Moreover, injecting mice with granulocyte colony-stimulating factor did not affect the differentiation of human STRC. These findings demonstrate that the differentiation capacity of human STRCs is developmentally regulated by mechanisms inaccessible to currently available hematopoietic growth factors, and explain why thrombopoiesis is deficient in clinical CB transplantation.

[1]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[2]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[3]  D. Kent,et al.  Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties , 2007, Proceedings of the National Academy of Sciences.

[4]  David G Kent,et al.  Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. , 2006, The Journal of clinical investigation.

[5]  C. von Kalle,et al.  Efficient marking of human cells with rapid but transient repopulating activity in autografted recipients. , 2005, Blood.

[6]  K. Ballen.  New trends in umbilical cord blood transplantation. , 2005, Blood.

[7]  Lina A. Thoren,et al.  Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential A Revised Road Map for Adult Blood Lineage Commitment , 2005, Cell.

[8]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[9]  J. Dick,et al.  Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells , 2003, Nature Medicine.

[10]  Pingfu Fu,et al.  Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. , 2003, Blood.

[11]  C. von Kalle,et al.  Polyclonal long-term repopulating stem cell clones in a primate model. , 2002, Blood.

[12]  Irving L. Weissman,et al.  Prospective isolation of human clonogenic common myeloid progenitors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Chan Zeng,et al.  Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  I. Weissman,et al.  Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. , 2002, The Journal of clinical investigation.

[15]  H. Mayani,et al.  In vitro proliferation, expansion, and differentiation of a CD34+ cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. , 2002, Archives of medical research.

[16]  E. Shpall,et al.  Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Eaves,et al.  Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype. , 2001, The Journal of clinical investigation.

[18]  B. Vandekerckhove,et al.  Both CD34+38+ and CD34+38− Cells Home Specifically to the Bone Marrow of NOD/LtSZ scid/scid Mice but Show Different Kinetics in Expansion1 , 2001, The Journal of Immunology.

[19]  Irving L. Weissman,et al.  The Fetal Liver Counterpart of Adult Common Lymphoid Progenitors Gives Rise to All Lymphoid Lineages, CD45+CD4+CD3− Cells, As Well As Macrophages1 , 2001, The Journal of Immunology.

[20]  C. von Kalle,et al.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. , 2001, The Journal of clinical investigation.

[21]  J. Cazenave,et al.  The αIIbβ3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+cord blood cells to megakaryocytes , 2000 .

[22]  T. Nakahata,et al.  Exclusive expression of G‐CSF receptor on myeloid progenitors in bone marrow CD34+ cells , 2000, British journal of haematology.

[23]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[24]  Nathalie Rufer,et al.  Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood , 1999, The Journal of experimental medicine.

[25]  M. Zenke,et al.  Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. , 1998, Blood.

[26]  W. Vainchenker,et al.  Effects of cytokines on platelet production from blood and marrow CD34+ cells. , 1998, Blood.

[27]  C. Civin,et al.  Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. , 1996, Blood.

[28]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[29]  J M Piret,et al.  Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin , 1996, The Journal of experimental medicine.

[30]  O. Majdic,et al.  Granulomonocyte-associated lysosomal protein expression during in vitro expansion and differentiation of CD34+ hematopoietic progenitor cells. , 1995, Blood.

[31]  I. Weissman,et al.  A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells , 1990, Cell.

[32]  G. Galbraith,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2008 .

[33]  C. von Kalle,et al.  Evidence of similar effects of short-term culture on the initial repopulating activity of mobilized peripheral blood transplants assessed in NOD/SCID-beta2microglobulin(null) mice and in autografted patients. , 2005, Experimental hematology.